Kaposi's sarcoma: its ‘oncogenes’ and growth factors
- 1 July 1991
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 11 (2) , 87-107
- https://doi.org/10.1016/1040-8428(91)90001-s
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.The Journal of Experimental Medicine, 1990
- The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brainCell, 1990
- Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.The Journal of cell biology, 1990
- Fibroblast Growth Factor Receptor Is a Portal of Cellular Entry for Herpes Simplex Virus Type 1Science, 1990
- Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor and basic fibroblast growth factor in a PC12 cell line.Molecular and Cellular Biology, 1990
- Isolation of cDNAs encoding four mouse FGF family members and characterization of their expression patterns during embryogenesisDevelopmental Biology, 1990
- Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A.The Journal of cell biology, 1989
- Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitroCell, 1989
- Tumor-related angiogenesisCritical Reviews in Oncology/Hematology, 1989
- Characterization of tumors produced by signal peptide‐basic fibroblast growth factor‐transformed cellsJournal of Cellular Biochemistry, 1989